Latest Oncology News

Physicians Discuss Potential of Frontline Triplet Regimens for RCC

January 27, 2023

During a Targeted Oncology case-based roundtable event, Alan Tan, MD, discussed with participants their experience with tyrosine kinase inhibitor/immunotherapy combinations and the most recent results of triplet trials.

Teclistamab Combination Shows Higher Response Rate in Multiple Myeloma

January 27, 2023

Emma Searle, PhD, discusses results of the MajestTEC-2 trial combining teclistamab with daratumumab and lenalidomide for patients with multiple myeloma presented at the 2022 American Society of Hematology Annual Meeting and Exposition.